Quick Comparison
| ALCAR | Magnesium L-Threonate | |
|---|---|---|
| Half-Life | 4-5 hours | 2-3 hours (threonate carrier), but brain magnesium levels increase cumulatively |
| Typical Dosage | Standard: 500-2000 mg daily in 1-2 doses. For cognitive support: 1000-2000 mg daily. For neuropathy: 1500-3000 mg daily. Take in the morning — may be mildly stimulating. | Standard: 1500-2000 mg Magnesium L-Threonate daily (providing 144 mg elemental magnesium). Often split into a daytime dose and a pre-bed dose. The Magtein brand uses 2000 mg daily (667 mg three times). |
| Administration | Oral (capsules, powder). Well-absorbed on an empty stomach. | Oral (capsules, powder). The L-threonate form is specifically chosen for brain penetration. |
| Research Papers | 9 papers | 10 papers |
| Categories |
Mechanism of Action
ALCAR
ALCAR crosses the blood-brain barrier via the organic cation transporter (OCTN2) more effectively than L-carnitine. In neurons, it is hydrolyzed by carnitine acetyltransferase to donate its acetyl group to coenzyme A, forming acetyl-CoA—which can then be used for acetylcholine synthesis via choline acetyltransferase, effectively providing raw material for the memory neurotransmitter. ALCAR also transports long-chain fatty acids across the inner mitochondrial membrane via the carnitine palmitoyltransferase system for beta-oxidation and ATP production. ALCAR activates nerve growth factor (NGF) signaling, possibly through modulation of NGF receptor (TrkA) expression or downstream MAPK/ERK pathways. It has antioxidant properties, reducing lipid peroxidation in mitochondrial membranes and scavenging free radicals. These mechanisms support cognitive function and neuroprotection.
Magnesium L-Threonate
The L-threonate carrier forms stable complexes with magnesium and transports it across the blood-brain barrier via specific transporters more effectively than inorganic magnesium salts or other chelated forms. Once in the brain, magnesium acts as a voltage-dependent blocker of the NMDA receptor channel at the physiological magnesium binding site within the ion pore, preventing excessive calcium influx and glutamate-mediated excitotoxicity. Magnesium also serves as a cofactor for over 300 enzymes including those involved in neurotransmitter synthesis (tyrosine hydroxylase, glutamic acid decarboxylase), ATP production (creatine kinase, pyruvate kinase), and DNA/RNA polymerase. Elevated brain magnesium enhances synaptic density and plasticity in the hippocampus and prefrontal cortex, likely through CREB-mediated gene expression and increased density of postsynaptic AMPA receptors.
Risks & Safety
ALCAR
Common
Nausea, fishy body odor, restlessness, gastrointestinal discomfort.
Serious
May increase agitation in Alzheimer's patients. TMAO production may be a cardiovascular concern with chronic high doses.
Rare
Seizures in susceptible individuals, increased thyroid activity.
Magnesium L-Threonate
Common
Drowsiness (often desired for sleep), mild headache initially, gastrointestinal discomfort.
Serious
None documented at standard doses. Magnesium toxicity is not a concern with oral supplementation in people with normal kidney function.
Rare
Diarrhea (less common than with other magnesium forms).
Full Profiles
ALCAR →
Acetyl-L-Carnitine is an acetylated form of L-Carnitine that crosses the blood-brain barrier more effectively than regular L-Carnitine. In the brain, it donates its acetyl group for acetylcholine synthesis and supports mitochondrial fatty acid oxidation for energy. Used clinically for age-related cognitive decline, depression, and diabetic neuropathy.
Magnesium L-Threonate →
A form of magnesium specifically designed to cross the blood-brain barrier and increase brain magnesium levels. Developed at MIT, it is the only magnesium form clinically shown to raise CSF magnesium concentrations. Brain magnesium is critical for synaptic plasticity, and deficiency (common in modern diets) impairs learning, memory, and sleep quality. Sold under the brand name Magtein.